IRDInov

IRDInov is a series of interregional seed funds managed by IRDI Capital Investissement, a leading private equity firm based in Southwestern France. Established in 2012 with the support of the French National Seed Fund (FNA) and regional authorities, IRDInov specializes in providing early-stage and seed capital to innovative startups and spin-offs from public and private research institutions. The funds maintain a significant focus on the life sciences sector, investing in biotechnology, medical technology, and digital health companies located in the Occitanie and Nouvelle-Aquitaine regions. Notable portfolio companies include Gamamabs Pharma, Fineheart, and Surgical Perspective. IRDInov plays a critical role in the regional innovation ecosystem by bridging the gap between academic research and commercial viability.